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Ubiquitin-dependent molecular chaperone p97, also known as valosin-containing protein
(VCP) or Cdc48, is an AAA ATPase involved in protein turnover and degradation. p97
converts its own ATPase hydrolysis into remodeling activity on a myriad of ubiquitinated
substrates from different cellular locations and pathways. In this way, p97 mediates
extraction of targeted protein from cellular compartments or protein complexes. p97-
dependent protein extraction from various cellular environments maintains cellular protein
homeostasis. In recent years, p97-dependent protein extraction from chromatin has
emerged as an essential evolutionarily conserved process for maintaining genome stability.
Inactivation of p97 segregase activity leads to accumulation of ubiquitinated substrates on
chromatin, consequently leading to protein-induced chromatin stress (PICHROS). PICHROS
directly and negatively affects multiple DNA metabolic processes, including replication,
damage responses, mitosis, and transcription, leading to genotoxic stress and genome
instability. By summarizing and critically evaluating recent data on p97 function in various
chromatin-associated protein degradation processes, we propose establishing p97 as a
genome caretaker.
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INTRODUCTION
Genome stability is a prerequisite for cell survival, cancer preven-
tion, and control of aging (Papamichos-Chronakis and Peterson,
2013). The genome is constantly attacked by various reactive
oxygen species from endogenous sources. In addition to endoge-
nous sources, DNA lesions can also be generated by a variety of
exogenous sources, such as ionizing radiations (IR), the ultravi-
olet light (UV), and many chemical agents, some of which are
products of our industrialized society. It is estimated that the
mammalian genome accumulates thousands of DNA lesions every
day that disturbDNA synthesis and cell division, two essential pro-
cesses in genome ampliﬁcation, preservation and transition to the
next generation (Jackson and Bartek, 2009). Failure to maintain
genome stability leads to chromosomal aberrations, gene muta-
tions, and cancer or cell death. Tomaintain genomic stability, cells
respond to DNA damage by activating a spatiotemporal signal-
ing pathway known as the DNA damage response (DDR; Ciccia
and Elledge, 2010). Following DNA damage, the DDR drives
cell cycle checkpoints and initiates DNA repair or induces apop-
tosis if the genome is severely damaged. Although DDR after
double-strand break (DSB) has been widely investigated and is
considered as a DDR model, other types of DNA lesions can
cause activation of lesion-speciﬁc DDRs that signal and recruit
appropriate sensor, transductor, and effector proteins (Jackson
and Bartek, 2009). For example, unrepaired DNA lesions that
enter S phase encounter a serious problem during DNA replica-
tion.When the DNA replication fork approaches these lesions, the
cell activates the DNA damage tolerance (DDT) pathway, which
enables survival by activating the translesionDNA synthesis (TLS)
pathway (Friedberg, 2005). The TLS pathway enables recruit-
ment of translesion DNA polymerases (DNA pols), which can
bypass bulky DNA lesions and ensure continuous DNA synthesis.
Activation of lesion-speciﬁc DDR and appropriate DNA repair
mechanisms or DDT ensures cell survival and prevents genomic
instability and cancer. DDR and DDT are controlled by various
post-translational modiﬁcations (PTMs) in which ubiquitination
and sumoylation play an essential role (Bergink and Jentsch, 2009;
Al-Hakim et al., 2010; Ulrich and Walden, 2010; Bekker-Jensen
and Mailand, 2011; Lehmann, 2011b; Psakhye and Jentsch, 2012).
Ubiquitination and sumoylation regulate timely assembly and dis-
assembly of various DNA repair and genome caretaker molecules.
Disturbances in this tight regulation could cause severe defects in
the DDR and lead to genomic instability, which has been demon-
strated in certain types of breast and ovarian cancers and patients
with RIDDLE syndrome (Blundred and Stewart, 2011; Lipkowitz
and Weissman, 2011). Mutations in BRCA1, an E3 ubiquitin lig-
ase involved in DDR, can result in breast and ovarian cancers,
while mutations in the DDR-related E3 ligase RNF168 can cause
RIDDLE syndrome, which is characterized by radiation hyper-
sensitivity, immunodeﬁciency, dysmorphic features, and learning
difﬁculties. Becausemany chromatin-associatedDDRproteins are
tightly bound to sites of DNAdamage and are often protected from
degradation, spatiotemporal turnover and degradation are facil-
itated by the ubiquitin-proteasome system (UPS; Dianov, 2011;
Levy-Barda et al., 2011; Ramadan and Meerang, 2011). It is still
not known how the UPS and its largest component, the pro-
teasome, approach, remove and degrade tightly bound protein
complexes on chromatin. Discovery of a p97 function related to
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chromatin may provide the answer (Dantuma and Hoppe, 2012;
Ramadan, 2012).
In recent years, ubiquitin-dependent molecular chaperone p97
has emerged as an essential regulator of UPS-dependent protein
turnover in chromatin. p97, also known as valosin-containing
protein (VCP) or Cdc48, a central element of the UPS and is
integrated downstream of substrate ubiquitination and upstream
of the proteasome. With intrinsic ATPase activity, p97 extracts
(segregates) polyubiquitinated proteins from diverse cellular loca-
tions and presents them for proteasomal degradation. p97 is also
involved in degradation of highly folded ubiquitinated soluble
proteasome substrates and thus functions as unfoldase (Beskow
et al., 2009). Recently elucidated functions of p97 in several DNA
metabolic processes indicate that the protein is a constitutive com-
ponent of various essential chromatin-related processes in the
cell cycle, DNA replication and repair, mitosis, and transcription.
However, the function of p97 as it relates to genome stability has
not yet been esteemed.
In this review, we discuss various p97 functions in chromatin-
related processes essential formaintenance of genome stability and
attempt to establish p97 as a genome caretaker. We also present a
large body of evidence suggesting that protein-induced chromatin
stress (PICHROS) induces genotoxic stress, ultimately leading to
genome instability.
UBIQUITIN-DEPENDENT MOLECULAR CHAPERONE p97
Molecular chaperone p97, also known as VCP in vertebrates,
Cdc48 in S. cerevisiae, Cdc-48 in C. elegans, TER94 in Drosophila,
andVAT in archaebacteria, is a class II member of theATPase asso-
ciated with diverse cellular activities (AAA) ATPases (Woodman,
2003; Halawani and Latterich, 2006; Jentsch and Rumpf, 2007;
Stolz et al., 2011; Meyer et al., 2012; Verma et al., 2013). p97 is
highly conserved from archaebacteria to humans and is one of the
most abundant proteins in the cytoplasm and nucleoplasm (Peters
et al., 1990). It is a homohexameric barrel-like molecular machine
composed of the following domains: N-terminal, two ATPase cas-
settes (D1 and D2) and a C-terminal domain (Figure 1A). The
N-terminal region of p97 binds a myriad of substrates primarily
embedded in different cellular structures, such as the endoplas-
mic reticulum (ER), ribosomes, membrane vesicles, spindles, or
chromosomes. After it is bound to the substrate, p97 uses ATP
hydrolysis in the D2 domain to stimulate major intrinsic confor-
mational changes that are transmitted throughout the entire p97
molecule to the N-terminal domain (Rouiller et al., 2002; Li et al.,
2012). Intrinsic conformational changes allow p97 to remodel and
thus extract (segregase activity) bound substrates fromdiverse cel-
lular structures or protein complexes. Beside its segregase activity
from different cellular structures, p97 serves as unfoldase in pro-
cessing of highly folded soluble proteasome substrates (Beskow
et al., 2009). The majority of p97 substrates are ubiquitinated,
and ubiquitin serves as a major regulator of p97 function (Ye,
2006). Identiﬁcation of Ufd1, one of the core p97 adapters, and
Ufd2, a p97-associated E4-ubiquitin ligase, as essential yeast genes
in degradation of soluble substrate by ubiquitin fusion degrada-
tion (UFD) pathway was the ﬁrst report of p97/Cdc48 function
in the UPS (Johnson et al., 1995). p97 acts as a segregase or
a molecular corkscrew for ubiquitinated substrates. Similar to
ubiquitin and the UPS, p97 is involved in diverse, unrelated cel-
lular functions and pathways. Interestingly, the speciﬁcity of p97
in diverse pathways and substrates is governed by different p97
adaptor proteins (also known as p97 cofactors) that typically pos-
sess ubiquitin-binding domains (Yeung et al., 2008; Hanzelmann
et al., 2011; Kloppsteck et al., 2012). In general, p97 adaptors are
only those proteins with p97-interacting domains or motifs, such
as the UBX (ubiquitin regulatory X) domain, UBD (ubiquitin
D) domain, PUB [PNGase (peptide N-glycosidase)/ubiquitin-
associated] domain, SHP motif, VIP (VCP interacting protein)
motif, or VBM (VCP-binding motif). UBX is the most prominent
p97 interacting domain and has a similar structure to ubiqui-
tin, but lacks sequence homology. There are at least 13 different
UBX domain-containing proteins (UBX proteins) in mammalian
cells, and their functions are largely uncharacterized. All UBX pro-
teins were recently shown to interact with p97 as major regulators
of p97 function (Alexandru et al., 2008). It is not known how
many different p97 adaptor complexes exist in the cell, but current
understanding of p97 and its adaptors suggests the existence of the
following three primarymutually exclusive p97 core adaptor com-
plexes: p97–Ufd1–Npl4 (p97−Udf1−Npl4), p97–p47 (p97−p47) and
p97–UBXD1 (p97−UBXD1; Meyer et al., 2012; Figure 1B). Each
of the p97 adaptor complexes is dedicated to a speciﬁc ubiquitin-
dependent cellular process. According to the “p97 core adaptor
hypothesis,” the p97−Ufd1−Npl4 complex is involved in regulat-
ing mostly Lys48-polyubiquitinated substrates and proteasomal
degradation in diverse cellular processes, such as ER-associated
degradation (ERAD), chromatin-associated protein degradation
(CAD), or ribosome-associated degradation (RAD). In contrast,
the p97 core complexes p97−p47 and p97−UBXD1 are involved in
ubiquitin-dependent proteasome-independent membrane fusion
and vesicular trafﬁcking processes. The speciﬁcity and activity
of p97 core adaptor complexes to different substrates relies on
a combination of secondary p97 adaptors in a process known
as the p97 adaptor hierarchy (Hanzelmann et al., 2011). This is
best illustrated in the p97−Npl4−Ufd1 complex, which processes
and remodels various polyubiquitinated substrates involved in
diverse pathways on the same cellular structure, such as chro-
matin (Alexandru et al., 2008; Verma et al., 2011; Davis et al., 2012;
Mosbech et al., 2012). For example, the p97−Ufd1−Npl4 core com-
plex is (i) recruited to stalled transcription by UBX4 and UBX5
(human homologs UBXD9 and UBXD7) and extracts RNA pol
II from chromatin or (ii) recruited to stalled DNA replication by
DNA damage-associated VCP/p97 cofactor 1 (DVC1; also known
as SPARTAN or C1orf124) and extracts DNA pol delta and eta
(Davis et al., 2012; Ghosal et al., 2012; Mosbech et al., 2012) or (iii)
binds soluble hypoxia inducible factor 1a by UBXD7 (Alexandru
et al., 2008). All of the proteins extracted, remodeled or unfolded
due to p97 segregase and/or unfoldase activities are ultimately
degraded by a proteasome.
In addition to its function in the UPS, in the last few years p97
function emerged in maintenance of cellular homeostasis by reg-
ulating two closely related processes, autophagy and endosomal
trafﬁcking (Ju et al., 2009; Tresse et al., 2010; Ritz et al., 2011).
p97 plays an essential role in maturation of ubiquitin-coating
autophagosomes, suggesting its function in autophagic degrada-
tion of ubiquitinated substrates. The focus of this review is the
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FIGURE 1 | p97 and its three core adaptors regulate diverse cellular
functions. (A) Domain structure of p97 monomer: N-terminal region
(yellow), L1 and L2 linker regions (gray), two ATPase cassettes D1 and D2
(green), and the C-terminal tail (blue). (B) p97 homohexamer forms a
barrel-like structure that mutually binds one of three core adaptor
complexes, Npl4–Ufd1 heterodimer, UBXD1 or p47, and regulates
diverse cellular functions as indicated in white boxes. ERAD,
endoplasmic reticulum-associated degradation; RAD,
ribosomal-associated degradation; CAD, chromatin-associated
degradation.
function of p97 in CAD and genome stability. For details on p97
function in autophagy and endosomal trafﬁcking, see elsewhere
(Ju andWeihl, 2010b; Bug and Meyer, 2012).
CHROMATIN-ASSOCIATED PROTEIN DEGRADATION AND
PROTEIN-INDUCED CHROMATIN STRESS
Chromatin is a large protein-integration platform in which struc-
tural, dynamic, and spatiotemporal association with proteins
involved in diverse processes, such as transcription, DNA repli-
cation, DNA repair, and cell division, must be tightly regulated.
Nearly every protein recruited to chromatin during these processes
that are essential for genome maintenance require timely removal
or disassembly. Various components of the UPS and protea-
some are tightly associated with chromatin, particularly when an
increased protein turnover rate is needed, as in cases of DNA dam-
age (Levy-Barda et al., 2011; Ramadan and Meerang, 2011; Butler
et al., 2012). CAD plays an essential role in maintaining genome
integrity and cellular homeostasis (Figure 2). Although chromatin
is a key site of protein turnovernecessary for genome stability,CAD
has recently emerged as an important component of chromatin
metabolism (Acs et al., 2011; Levy-Barda et al., 2011; Meerang
et al., 2011; Feng and Chen, 2012; Galanty et al., 2012; Gudjonsson
et al., 2012; Mallette et al., 2012; Mattiroli et al., 2012; Ramadan,
2012; Yin et al., 2012). Many proteins that operate on chromatin
are tightly bound to the chromatin structure or chromatin-
associated processes and are even considered insoluble. In addition
to the physical presence of proteasomes in the vicinity of chro-
matin, mechanical force is needed to remodel and disassemble
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FIGURE 2 | Chromatin-associated protein degradation (CAD) regulated
by p97–Ufd1–Npl4. Chromatin-bound proteins (S represents any known p97
substrate on chromatin) are polyubiquitinated and sumoylated by speciﬁc E3
ubiquitin and SUMO ligases. p97−Ufd1−Npl4 complex is recruited to
polyubiquitinated substrates by a ubiquitin-binding domain in Npl4 or Ufd1.
ATP hydrolysis, located in the D2 ATPase cassette, induces conformational
changes in the p97 molecule to remodel and release chromatin-bound
substrates. Extracted substrates are either degraded by proteasomes or
recycled. The p97−Ufd1−Npl4 complex maintains CAD and prevents
PICHROS.
chromatin-bound substrates for ﬁnal removal and degradation.
Discovery of the ubiquitin-dependent molecular segregase p97 as
an integral part of CAD sheds new light on how cells disassem-
ble proteins from chromatin (Ramadan, 2012). Inactivation of
p97 by RNAi or p97 segregase mutants in various systems (e.g.,
yeast and humans) causes K48-polyubiquitinated p97 substrates
to accumulate on chromatin, leading to PICHROS. PICHROS
negatively affects downstream events that involve accumulated
substrates, such as DNA replication, DNA repair, mitosis, and
transcription (Figure 3; Ramadan et al., 2007; Franz et al., 2011;
Meerang et al., 2011; Raman et al., 2011; Verma et al., 2011). To
our knowledge, the ﬁrst identiﬁed chromatin-associated substrate
of p97 was Aurora B (Ramadan et al., 2007). Since this discov-
ery, information regarding removal of chromatin substrates by
ubiquitin-dependent p97 activity has rapidly progressed (Wilcox
and Laney, 2009; Acs et al., 2011; Franz et al., 2011; Meerang et al.,
2011; Raman et al., 2011; Davis et al., 2012; Ghosal et al., 2012;
Mosbech et al., 2012). The importance of CAD function in genome
stability was further conﬁrmed by discovery of K48 ubiquitinated
substrates orchestrated by E3 ubiquitin ligase RNF8 and p97 at
sites of DNA damage (Meerang et al., 2011). Understanding the
function of CAD in genome stability has rapidly progressed (see
above). Tight collaboration between ubiquitination and sumoyla-
tion at sites of DNA damage plays a role in CAD. The evolutionary
conserved SUMO-targeted E3 ubiquitin ligase (STUbL) RNF4 in
mammals, Slx5–Slx8 in budding yeast and Rfp1/2–Slx8 in ﬁssion
yeast is recruited to sumoylated substrates at sites of DNA dam-
age (Prudden et al., 2007; Galanty et al., 2012; Yin et al., 2012).
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FIGURE 3 | Protein-induced chromatin stress (PICHROS). As indicated in
Figure 2, chromatin-bound substrates are polyubiquitinated, but cannot be
removed due to inactivation of p97. Accumulation of polyubiquitinated
substrates on chromatin causes PICHROS that severely disturbs, mostly
inhibits, essential DNA metabolic processes, such as DNA replication,
transcription, or DNA repair, and leads to genome instability.
STUbL polyubiquitinates SUMO-modiﬁed proteins and primes
them for proteasomal degradation. Inactivation of STUbL causes
hyperaccumulation of SUMO conjugates and SUMO-induced cell
toxicity. In human cell lines, RNF4 is recruited to sumoylated
substrates and polyubiquitinates DSB-induced factors, such as
mediator of DNA damage checkpoint 1 (MDC1) and replication
factor A (RPA). Consequently, polyubiquitinated MDC1 and RPA
are removed from sites of damage in a proteasome-dependent
manner (Shi et al., 2008; Galanty et al., 2012). RNF4-dependent
MDC1 and RPA turnover allow recruitment of downstream fac-
tors, such as BRCA2 and Rad51, essential for efﬁcient DNA repair.
Inactivation of RNF4 also causes persistence of other factors at
sites of damage, such as E3 ubiquitin ligases RNF8 and RNF168
and DNA damage signaling factor 53BP1 (Yin et al., 2012). Two
additional E3 ubiquitin ligases, UBR5 and TRIP12, are involved in
CAD and protection from PICHROS (Gudjonsson et al., 2012).
UBR5 and TRIP12 regulate turnover of RNF168, the primary
E3 ubiquitin ligase that ubiquitinates histones after DSBs. Deple-
tion of UBR5 and TRIP12 causes hyperaccumulation of RNF168
and a signiﬁcant increase in ubiquitin conjugates, which stim-
ulates widespread accumulation of ubiquitin-dependent factors
53BP1 and BRCA1. Deregulation of spatiotemporal SUMO- and
ubiquitin-dependent protein turnover may cause hyperaccumu-
lation of various proteins on chromatin, consequently leading
to PICHROS and genome instability. In the following text,
we will focus on p97-dependent CAD and PICHROS directly
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related to genome stability. We will also elaborate the func-
tion of p97 in cell cycle, which may indirectly affect genome
stability.
p97 IN THE CELL CYCLE
Cell cycle progression can be simpliﬁed into two main processes,
DNA replication (S phase) and segregation of replicated chromo-
somes into two daughter cells (M phase). The G1 and G2 phases
are intercalated to ensure that all requirements necessary for safe
DNAreplication and segregation are achieved. The transition from
one cell cycle phase to another is controlled by numerous mech-
anisms to ensure correct cell division. Cyclin-dependent kinases
(CDKs) play a central role in cell cycle progression. The activity
of CDKs is coordinated by transcription and ubiquitin-dependent
degradation of different cell cycle-speciﬁc cyclins, CDK inhibitors,
and phosphatases (Malumbres and Barbacid, 2009). Additionally,
checkpoint mechanisms activated upon DNA damage ensure the
quality of DNA during replication and segregation (Branzei and
Foiani, 2009).
The Cdc48 gene (p97 homolog) was identiﬁed in the ﬁrst
genetic screen for cell division cycle (cdc) mutants in yeast (Moir
et al., 1982). Cdc48 generally attaches to the ER, but relocalizes
in the nucleus after phosphorylation in a cell cycle-dependent
manner (Madeo et al., 1998). Several observations in yeast and
other organisms have revealed that Cdc48 is crucial for normal
cell cycle progression and associated genomic stability (Mouys-
set et al., 2008; Deichsel et al., 2009). In yeast, mutations in the
Cdc48 gene cause delayed G1/S transition and G2/M arrest. In
C. elegans embryos, depletion of Cdc-48 or one of its cofactors,
Ufd-1 or Npl-4, causes delays in S phase progression due to acti-
vation of replication checkpoints (Mouysset et al., 2008). p97 or
Ufd1–Npl4 inactivation also leads to delayed progression through
anaphase and exit from mitosis in human cell lines and Xeno-
pus egg extracts (Ramadan et al., 2007; Dobrynin et al., 2011).
These p97-defective phenotypes clearly demonstrate the crucial
function of p97 in different phases of the cell cycle. p97 is impor-
tant for protein degradation, and cell cycle progression requires
removal/degradation of cell cycle related proteins. Determining
the role of p97 in regulating these processes is important for under-
standing how protein recycle/degradation affects the normal cell
cycle.
p97 IN G1/S TRANSITION
Many cell fate decisions are determined in the G1 phase of the
cell cycle. A key question is whether or not to proliferate (repli-
cate). When the cellular environment is favorable, cells initiate the
division cycle. The cellular commitment to replicate the genome
and divide is known as the restriction point. After passing the
restriction point, cells switch from mitogen-dependent growth in
early G1 to growth factor-independent progression in S phase,
which is controlled by the retinoblastoma protein (pRb) and the
cdk4/cyclin D complex. Cdk4/cyclin D hyperphosphorylates pRb,
which consequently releases E2F transcription factors that activate
transcription of several regulatory genes necessary for G1/S tran-
sition and S phase progression, such as cyclin E and cyclin A. The
activity of cdk4/cyclin D needs to be tightly regulated (Malumbres
and Barbacid, 2009).
Mutations in the Cdc48 gene delay G1/S transition in budding
yeast (Fu et al., 2003). Cdc28/Cln, a yeast Cdk1/cyclin important
forG1/S transition controls the execution of Start (a yeast cell cycle
commitment point equivalent to the restriction point in mam-
malian cells). Far1p is a Cdc28/Cln inhibitor and its degradation is
needed forG1/S progression. Cdc48 physically interactswith ubiq-
uitinated Far1p and stimulates its degradation. The defect in G1/S
transition after Cdc48 inactivation was shown to be due to persis-
tence of the Cdc28/Cln inhibitor Far1p. In contrast to normal cells
inwhich Far1p is degraded following release fromG1 arrest,Cdc48
mutant cells accumulated ubiquitinated Far1p. G1/S delay could
be rescued following mutations in both Cdc48 and Far1p genes,
clearly suggesting that Cdc48 is required for Far1p degradation.
Although no data are available, a similar p97-dependent process
could exist in higher eukaryotes in which CDK activity is also
regulated by CDK inhibitors. In addition to Far1p degradation,
Cdc48−Ufd1−Npl4 complex controls G1/S transition via cell wall
integrity pathway mechanisms in yeast (Hsieh and Chen, 2011).
The mechanisms by which Cdc48 controls cell wall integrity have
not been determined, although Cdc48 appears to regulate Mpk1
activity, which is a MAP kinase family member important for
cell wall integrity, in response to stress conditions, including heat
shock.
p97 IN DNA REPLICATION AND S PHASE
To divide and preserve an intact genome, cells must tightly reg-
ulate DNA replication. DNA synthesis occurs in the S phase,
but preparation starts in late mitosis and G1 by loading a pre-
replicative complex (pre-RC) at each origin of replication. Some
pre-RCs are active, while others remain dormant. Pre-RCs consist
of an origin recognition complex (ORC), cell division con-
trol protein (Cdc6), chromatin licensing and replication factor
(Cdt1), and the minichromosome maintenance (MCM) heli-
case complex. Pre-RC is activated by phosphorylation to recruit
essential replication factors, such as MCM-10, CDC-45, and the
Go–Ichi–Ni–San complex (GINS), to form a pre-initiation com-
plex (pre-IC), which recruits DNA primase and polymerases to
initiate DNA synthesis. After the origins ﬁre, the pre-RC fac-
tors are removed or inhibited to prevent re-replication of the
genome during the same cell cycle. Various obstacles during
DNA synthesis, such as secondary DNA structures, DNA–protein
complexes or damaged bases, can stall the fork or lead to fork
collapse. To ensure that the DNA replication fork can handle
all of these challenges, cells activate an intra-S phase checkpoint
(Branzei and Foiani, 2010).
p97 function includes regulation of DNA replication and pro-
gression through the S phase (Mouysset et al., 2008). Depletion of
Cdc-48 (p97) or its adaptors Ufd-1 or Npl-4 in C. elegans signiﬁ-
cantly delays progression through the S phase due to activation of
atl1 (ATR) and the Chk1-dependent intra-S phase checkpoint.
Depletion of Cdc-48, Ufd-1, or Npl-4 reduces the number of
nuclei and total amount of DNA and increases the number of
chromosomal bridges in C. elegans embryos. Depletion of intra-
S phase checkpoint kinases completely restores the delay in S
phase progression in Cdc-48-, Npl-4-, or Ufd-1-defective cells,
but could not restore the number of nuclei, DNA content or
decrease the number of chromosomal bridges. Recent work by
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two independent groups providedmechanistic insight into the role
of p97−Ufd1−Npl4 in DNA replication (Franz et al., 2011; Raman
et al., 2011). The research groups showed that p97 regulates Cdt1
chromatin turnover and stability via two distinct pathways, (i)
a UV lesion-related pathway (Raman et al., 2011) and (ii) ﬁr-
ing and elongation of the replication fork (Franz et al., 2011).
In the UV lesion-related pathway, p97 regulates destruction of
Cdt1 at sites of UV-induced DNA damage. After UV damage,
nucleotide excision repair (NER) machinery recognizes distorted
DNA (thymine dimers) and excises damaged DNA strands 25–30
nucleotides in length. This gap is repaired by DNA polymerization
in proliferating cell nuclear antigen (PCNA)- and E3 ubiqui-
tin ligase Cul4–DDB2-dependent manners. Cdt1 associates with
PCNA to initiate DNA replication at sites of damage, but must
be tightly regulated to prevent re-replication. After initiation of
DNA synthesis, PCNA-bound Cdt1 is polyubiquitinated by Cul4–
DDB2, extracted from chromatin in a p97−Ufd1−Npl4-dependent
manner and presented to the proteasome for ﬁnal degradation
(Raman et al., 2011). p97 directly controls gap-ﬁlling DNA syn-
thesis after UV damage. In the second pathway, p97 controls DNA
replication by extracting polyubiquitinated Cdt1 from chromatin
under physiological conditions in C. elegans and a Xenopus egg
extract. Inactivation of the p97−Ufd1−Npl4 complex stabilizes Cdt1
on interphase and mitotic chromatin. Consequently, Cdc45 and
GINS are stabilized on chromatin-bound Cdt1 and could inter-
fere with DNA replication fork elongation (Franz et al., 2011).
Cdc-48/p97 depletion leads to accumulation of Cdt1 on chro-
matin in C. elegans embryos, Xenopus egg extract and human cell
lines. Re-replication, a typical phenotype caused by Cdt1 over-
expression, was not observed in p97/Cdc-48 depleted cells. In
contrast, two independent research studies showed that inacti-
vation of p97 caused G2/M arrest in human embryonic kidney
cell line (HEK293) and decreased the total DNA content in C.
elegans (Mouysset et al., 2008; Raman et al., 2011). This is diamet-
rically different from a typical re-replication phenotype, which
involves an increased amount of total DNA characterized by ele-
vated Cdt1 protein levels (Teer and Dutta, 2008; Ramanathan and
Ye, 2011). The molecular mechanisms involving p97 regulation
of DNA replication cannot be simply attributed to extraction and
stability of Cdt1 fromchromatin. However, the evolutionarily con-
served function of p97−Ufd1−Npl4 in DNA replication has been
demonstrated (Mouysset et al., 2008; Deichsel et al., 2009; Franz
et al., 2011; Raman et al., 2011). p97 most likely regulates multi-
ple steps during DNA synthesis. This hypothesis could be further
supported by direct physical interactions with several replicative
helicases, such as the Werner protein and HIM-6 (Bloom heli-
case homolog; Partridge et al., 2003; Indig et al., 2004; Caruso
et al., 2008).
p97 IN MITOSIS
Mitosis is characterized by profound changes in cell physiology
that allow nuclear envelope disassembly and separation of genetic
material into two daughter cells. Spatiotemporal coordination
of complex mitotic processes depends on phosphorylation and
ubiquitination events that are crucial for genome integrity. At the
end of mitosis, inhibition/degradation of several kinases, such as
cyclin B and Aurora B, leads to spindle disassembly, cytokinesis,
chromatin decondensation, and nuclear envelope reformation
(Carmena et al., 2012).
Aurora B was the ﬁrst p97 substrate discovered in chromatin
(Ramadan et al., 2007). In Xenopus egg extracts and C. elegans,
p97/Cdc-48−Ufd1−Npl4 binds polyubiquitinated Aurora B and
extracts it from mitotic chromatin. p97-dependent removal of
Aurora B allows chromatin decondensation and nuclear envelope
formation during exit from mitosis. A similar mechanism was
observed in human cell lines, although regulation of Aurora B
activity by p97 initiates much earlier during mitosis (Dobrynin
et al., 2011). Depletion of Ufd1 or Npl4 causes an increase in
Aurora B activity, which leads to defects in chromosomal align-
ment in anaphase, resulting in missegregated chromosomes and
multi-lobed nuclei. These results establish p97−Ufd1−Npl4 as a
negative regulator of Aurora B activity, which regulates multistep
processes in chromosome dynamics during mitosis.
Similarly, Cdc-48 in C. elegans was shown to be required for
proper condensation and segregation of meiotic chromosomes
by controlling AIR-2/Aurora B (Sasagawa et al., 2012). Cdc-48 is
required for localization of AIR-2 at regions between homologous
chromosomes in meiosis I. In the absence of Cdc-48, higher levels
of AIR-2 increase phosphorylation of its substrates over the entire
length of the chromosomes, leading to defective chromosome
segregation.
In contrast to the p97−Ufd1−Npl4 core complex, which extracts
and inactivates Aurora B in mitosis, another p97 core complex
(p97−p47) balances Aurora B activity in mitosis using a different
mechanism (Cheng and Chen, 2010). The Cdc-48−Shp1 complex
(p97−p47 in metazoans) facilitates nuclear localization of Glc7,
the yeast ortholog of protein phosphatase-1 (PP1), which coun-
teracts Aurora B kinase activity. Inactivation of the Cdc-48−Shp1
complex causes cell cycle arrest in metaphase due to a defect in
bipolar attachment of the kinetochore that activates the spindle
checkpoint.
In addition to Aurora B regulation, Cdc48/p97 is required for
proper spindle disassembly at the end of mitosis (Cao et al., 2003).
Xenopus egg extracts containing the dominant negative form of
p97 (p97QQ) or depleted of Ufd1 or Npl4 cofactors were unable
to disassemble the spindle and reform interphase microtubules
(MTs) and remained in a mitotic state. Cdc48/p97−Ufd1−Npl4
speciﬁcally interacts with spindle assembly factors XMAP215,
TPX2, and Plx1 at the exit of mitosis, promoting its sequestra-
tion in the cytoplasm or extraction from MTs. This function of
p97 was further conﬁrmed in yeast where p97 (Cdc48) is required
for degradation of spindle assembly factors Ase1 and Cdc5.
In conclusion, two p97 core complexes, p97−Npl4−Ufd1 and
p97−p47, coordinate Aurora B activity in chromatin to allow
proper chromosomal alignment, segregation, decondensation,
and nuclear envelope formation at mitotic exit. In addition to
direct effects on mitotic chromatin, the p97−Ufd1−Npl4 complex
also regulates spindle disassembly at the end of mitosis.
p97 IN DNA DAMAGE
To cope with DNA damage, preserve genetic information for the
next generation and survive, cells have evolved a variety of DNA
repair mechanisms speciﬁc for different types of damage, which
are orchestrated by DDR and DDT (Nyberg et al., 2002; Jackson
www.frontiersin.org April 2013 | Volume 4 | Article 60 | 7
“fgene-04-00060” — 2013/4/29 — 15:29 — page 8 — #8
Vaz et al. p97/VCP in genome stability
and Bartek, 2009; Curtin, 2012). Although p97 phosphorylation
after IR and physical interaction with BRCA1 predicted the role of
p97 in DNA repair more than a decade ago, its function in DNA
repair remained a mystery (Zhang et al., 2000; Livingstone et al.,
2005). The molecular mechanism of p97 emerged in DSB repair,
TLS and transcription-coupled NER (TC-NER) only recently
(Acs et al., 2011; Meerang et al., 2011; Verma et al., 2011; Davis
et al., 2012; Ghosal et al., 2012; Mosbech et al., 2012). Whether
p97 is involved in other DNA repair pathways remains to be
discovered.
DVC1 LINKS p97 TO TRANSLESION DNA SYNTHESIS
DNA is particularly vulnerable to damage during DNA replica-
tion. Some base adducts may escape detection by repair proteins
before progression through the S phase. During replication, these
lesions cannot be accommodated at the active sites of replica-
tive DNA pols and stall progression of the DNA replication fork
(Lehmann, 2011a). Stalled replication forks activate DDT path-
ways and recruits translesional DNA pols, a mechanism known as
TLS (Ulrich, 2007; Sale et al., 2012). TLS uses a DNA pol switch
mechanism, modulated by the ubiquitination status of PCNA, in
which replicative DNA pols are exchanged for translesion DNA
pols (Lehmann, 2011b).
Translesion DNA synthesis is initiated by monoubiquitination
of PCNA by the E3 ubiquitin ligase Rad18. Specialized translesion
DNA pols are recruited to monoubiquitinated PCNA at stalled
replication forks to promote bypass of damaged DNA. How-
ever, replication through a lesion site often requires the sequential
action of two DNA pols in which one inserts a nucleotide opposite
the damage (DNA pol eta) and the other extends from the inserted
nucleotide (DNA pol zeta; Lange et al., 2011). After lesion bypass,
PCNA is deubiquitinated by ubiquitin protease USP1, which stim-
ulates the switch from translesion to replicative polymerases and
continuation of DNA replication (Fox et al., 2011).
A newly identiﬁed p97 adaptor, DVC1, also known as Spartan,
recently emerged as a central factor in TLS (Centore et al., 2012;
Davis et al., 2012; Ghosal et al., 2012; Juhasz et al., 2012; Machida
et al., 2012; Mosbech et al., 2012; Kim et al., 2013). DVC1 is con-
served from C. elegans to humans and it localizes to UV-induced
DNA lesions and other DNA replication-related damage, but not
to DSBs induced by IR. DVC1 depleted cells were shown to be
sensitive to various replication-related genotoxic agents. Together
with physical interaction and cellular colocalization with PCNA,
these ﬁndings emphasize the role of DVC1 in replication-related
DNA damage processes, but not DSB repair after IR.
DVC1 contains several domains, such as a putative zinc metal-
loprotease domain (SprT), a p97-interactingmotif (SHP), a PCNA
interaction domain (PIP), and a zinc ﬁnger ubiquitin-binding
domain (UBZ4), that link its function to ubiquitin-dependent
and p97-regulated replication-related processes (Davis et al., 2012;
Ghosal et al., 2012; Mosbech et al., 2012). In addition to inter-
acting with PCNA, DVC1 interacts with other essential proteins
involved inDNA replication, TLS, andUPS, such asDNApol delta,
eta, Rad18, ubiquitin, and the p97−Ufd1−Npl4 complex (Centore
et al., 2012; Davis et al., 2012; Ghosal et al., 2012; Machida et al.,
2012; Mosbech et al., 2012; Kim et al., 2013). DVC1 was shown to
directly interact with p97 at the SHP domain, which is essential
for recruiting p97 to stalled replication forks. DVC1 lacking the
SHP domain can colocalize with DNA lesions, but cannot recruit
p97. These data suggest undisputable roles of DVC1 and p97 in
TLS synthesis.
However, the exact mechanism of DVC1 function and its
collaboration with p97 at stalled replication forks are still not
completely understood. First, it is not clear whether recruitment
of DVC1 to stalled replication forks depends on Rad18 E3 ligase.
Although three research groups claim that DVC1 recruitment to
UV lesions is dependent on Rad18 (Centore et al., 2012; Ghosal
et al., 2012; Juhasz et al., 2012), two other research groups have
reported thatDVC1 recruitment does not dependonRad18 (Davis
et al., 2012; Mosbech et al., 2012). Second, two groups claim that
DVC1 brings Rad18 to chromatin and enhances monoubiquiti-
nation of PCNA (Centore et al., 2012; Ghosal et al., 2012), while
others did not observe this effect. Third, one research group also
suggested that DVC1 is recruited to stalled replication forks by
Rad18 and PCNA-monoubiquitination, protecting monoubiqui-
tinated PCNA from deubiquitination (Juhasz et al., 2012). Fourth,
two groups have reported that DVC1 recruits p97 to stalled repli-
cation forks to extract DNA pol eta and allows the switch to
replicative polymerases after bypassing the UV lesion (Davis et al.,
2012; Mosbech et al., 2012). In contrast, one group showed that
DVC1 has an opposite function by removing replicative poly-
merase delta at UV lesions to allow recruitment of DNA pol eta
(Ghosal et al., 2012).
In addition to above-mentioned DVC1 function in error-free
TLS orchestrated by the switch betweenDNApol eta andDNApol
delta, DVC1 also negatively inﬂuences error-prone TLS orches-
trated by a DNA pol eta/DNA pol zeta switch supported by Rev1
and PolD3 (Kim et al., 2013). DVC1 and its SprT domain suppress
PolD3 from binding to DNA pol zeta to inhibit error-prone TLS.
Even thought the exact mechanistic insight of DVC1 in TLS is
not yet clear, DVC1 plays a crucial role in TLS, likely by stimulating
error-free TLS and inhibiting error-prone TLS. Further research
will be needed to elucidate the exact function of DVC1 at stalled
replication forks and involvement of p97.
p97 IN DNA DOUBLE-STRAND BREAK REPAIR AND DAMAGE RESPONSE
Double-strand break is the most deleterious DNA lesion. If not
repaired, it can cause chromosomal rearrangements, deletions and
genome instability or cell death. A single DSB can cause cell lethal-
ity in yeast, suggesting that it is a highly cytotoxic DNA lesion
that must be immediately detected and processed (Bennett et al.,
1993). It is estimated that approximately 1%of endogenous single-
strandDNA breaks convert to DSBs during S phase inmammalian
cells, which correlates to about 50 endogenous DSBs per cell cycle
(Vilenchik and Knudson, 2003). DSBs also occur as a consequence
of certain medical interventions related to diagnostics or therapy
(e.g., X-ray). To prevent genome instability, ubiquitination and
sumoylation have emerged as an essential PTM in regulating DDR
and DSB repair.
Until recently, the RNF8/RNF168-dependent Lys63-ubiquitin
chain was regarded as the sole ubiquitin-signaling pathway at
sites of DSB (Doil et al., 2009; Stewart et al., 2009; Al-Hakim
et al., 2010; Ulrich and Walden, 2010; Mattiroli et al., 2012). This
paradigm changed when p97 function was identiﬁed in DDR and
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DSB repair (Acs et al., 2011; Meerang et al., 2011; Ramadan, 2012).
The p97Ufd1−Npl4 complex is recruited to sites of DSB soon after
damage occurs. Recruitment of the p97Ufd1−Npl4 complex to sites
of DSBs strongly depends on free nuclear ubiquitin and RNF8
E3-ubiquitin ligase activity, but not E3 ligase RNF168 (Meerang
et al., 2011). This suggests the presence of an RNF8/RNF168-
orchestrated cascade and a sole RNF8-orchestrated cascade at
DNB sites, which was conﬁrmed using ubiquitin chain-speciﬁc
Lys63 or Lys48 antibodies. While depletion of RNF8 and RNF168
completely abolished formation of the Lys63- and Lys48-ubiquitin
chains at sites of DNA damage, depletion of RNF168 only elim-
inated Lys63-ubiquitin chain formation. Recruitment of p97 to
DSB sites strongly depends on RNF8/K48-ubiquitin chain forma-
tion. Depletion of p97 or expression of p97 segregase mutants
caused increased levels and persistence of Lys48-ubiquitin chains
atDSB sites. These data clearly demonstrate that p97 is recruited to
DSB sites via Lys48-ubiquitin chains formed by RNF8 and extracts
them from chromatin. p97 processing of Lys48-ubiquitinated sub-
strates soon after DSBs is important for recruiting signaling and
repair molecules, such as 53BP1, BRCA1, and Rad51 (Meerang
et al., 2011). The inability of p97-inactivated cells to process Lys48-
ubiquitinated substrates at sites of DSBs severely reduces the main
branches of DSB repair, homologous recombination, and non-
homologous end-joining. The speciﬁc p97 substrates at sites of
DNA damage and mechanisms by which p97 inﬂuences the main
branches of the DSB repair pathway remain unknown. Discovery
of the p97 substrate polycomb protein L3MBTL1 in the vicinity
of DSBs explains why inactivation of p97 segregase activity elim-
inated 53BP1 protein recruitment. L3MBTL1 possesses multiple
tandem Tudor domains, which enable its high afﬁnity to bind
H4Lys20me2 in undamaged chromatin (Acs et al., 2011). After
DSBs occur, L3MBTL1 is removed by p97 and allows recruitment
of 53BP1 by its own Tudor domain to H4Lys20me2. p97 regula-
tion in recruiting two other essential signaling and repair proteins,
BRCA1 andRad51, remains to be investigated. These data establish
previously unrecognized RNF8-Lys48 ubiquitin cascades at DSB
sites, which recruit p97−Ufd1−Npl4 segregase activity to process
Lys48-ubiquitin substrates (Ramadan, 2012).
Cdc48−Ufd1−Npl4, a yeast homolog of p97Ufd1−Npl4, is
involved in processing sumoylated and ubiquitinated substrates
at sites of DNA damage (Nie et al., 2012). Yeast Ufd1 con-
tains a SUMO-interacting motif (SIM) that non-covalently binds
SUMO conjugates and recruits the Cdc48−Ufd1−Npl4 complex
to STUbL targets. Cdc48−Ufd1−Npl4 cooperates with STUbL in
DNA repair to reduce stalled covalent DNA topoisomerase1-DNA
adducts by binding and processing sumoylated and ubiquiti-
nated substrates at sites of DNA damage. Whether the human
p97−Ufd1−Npl4 complex also participates in dual recognition of
sumoylated and ubiquitinated substrates at sites of DNAdamage is
not known.
p97 IN TRANSCRIPTION-COUPLED NUCLEOTIDE EXCISION REPAIR
A wide variety of DNA helix-distorting lesions, such as UV-
induced photolesions (thymine dimers) and DNA adducts
induced by chemicals in transcribed DNA, block progression of
the RNA pol II complex. Blocking transcription at sites of DNA
damage represents a serious obstacle forDNAreplication and leads
to DNA replication fork collapse. To prevent DNA replication fork
collapse at sites of stalled transcription and avoid apoptosis, cells
activate TC-NER, a subpathway of NER. TC-NER rapidly removes
lesions from the transcribed strand and allows transcription to
continue (Fousteri andMullenders, 2008; Lehmann, 2011a). Upon
induction of DNA damage by UV or UV-mimetic drugs, thymine
dimers form, transcription stalls, and the TC-NER subpathway is
activated. Stalled transcription recruits E3 ubiquitin ligase Cul3 to
ubiquitinate the RNA pol II complex and prime it for proteasomal
degradation (Chen et al., 2007; Ribar et al., 2007). It is hypothe-
sized that the stalled RNA pol II complex shields DNA lesions and
prevents access by the NER machinery. As a result, the complex
must be removed and degraded. The Cdc48Ufd1−Npl4 complex
together with Ubx4 and Ubx5 (human homologous UBXD9 and
UBXD7) play an important role in UV-dependent turnover of
the stalled RNA pol II complex in yeast (Verma et al., 2011). The
Cdc48Ufd1−Npl4−Ubx4−Ubx5 complex is recruited at sites of UV-
induced damage and facilitates CAD of Rpb1, the largest RNA
pol II subunit. The stalled RNA pol II complex also stimulates
increased proteasome recruitment at sites of UV lesions that form
a tight complex with p97/Cdc48. These results suggest tight coop-
eration between p97/Cdc48 andproteasomes at sites of UV lesions,
in the earliest step of TC-NER. Beside its involvement in the
upstream step of TC-NER, p97 also operates in the gap-ﬁlling
DNA synthesis, which is the ﬁnal step of both NER subpathways,
TC-NER and global genome-NER (GG-NER; Raman et al., 2011).
During gap synthesis, p97 promotes segregation and degrada-
tion of PCNA-bound Cdt1 to prevent re-replication (Raman et al.,
2011; Ramanathan and Ye, 2011). Together, these results suggest
that p97 operates at different levels in both NER subpathways. It
would be interesting to see whether and how p97 operates in early
steps of GG-NER.
p97 AND DISEASES RELATED TO GENOME STABILITY
p97 has been implicated in the pathogenesis of many human dis-
eases, including breast, colorectal, lung, prostate and pancreatic
cancers, chronic obstructive pulmonary disease and severe emphy-
sema, cystic ﬁbrosis, Alpha-1-trypsin deﬁciency, Paget’s disease of
bone, and several types of neurodegenerative disorders (Vij, 2008;
Haines, 2010; Min et al., 2011). Inclusion body myopathy asso-
ciated with Paget’s disease of bone and frontotemporal dementia
(IBMPFD) is the only disorder that has been directly linked to
p97 dysfunction to date (Kimonis et al., 2008). p97 mutations
have been linked to 2% of isolated familial amyotrophic lateral
sclerosis (ALS; Johnson et al., 2010). IBMPFD is an autosomal
dominant negative inherited degenerative disorder due to a single
missense mutation in p97 in humans. There are several families
with IBMPFD worldwide, but the mutations are primarily located
in theN-terminal region, the linker region between theN-terminal
and D1 areas and the D1 region (Weihl et al., 2009). IBMPFD is
characterized by disabling weakness, osteolytic lesions consistent
with Paget’s disease of bone and frontotemporal dementia. Accu-
mulation of cytoplasmic and nuclear ubiquitin-positive aggregates
in the tissues of patients with IBMPFD suggests that p97 process-
ing of ubiquitinated substrates is the key mechanism involved in
pathogenesis. Because p97 processes substrates for lysosomal and
proteasomal degradation pathways, it is not clear which pathway
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is affected in IBMPFD (Janiesch et al., 2007; Ju and Weihl, 2010a;
Ritz et al., 2011).
IBMPFD patients do not suffer from genomic instability phe-
notypes characterized by premature aging and/or cancer develop-
ment. For example, the incidence of osteosarcoma complications
in Paget’s disease of bone is less than 1% (Hansen et al., 2006).
In contrast, proteasomal degradation plays a crucial role in var-
ious aspects of genome stability (Shi et al., 2008; Ramadan and
Meerang, 2011; Galanty et al., 2012; Ramadan, 2012). Defects in
lysosomal degradation rather than defects in proteasomal degra-
dation likely contribute to the pathogenesis of IBMPFD. There is
evidence to support the hypothesis that defective p97 functioning
in lysosomal degradation is the primary cause of IBMPFD.
Although there is no direct proof that p97 mutations play
a role in diseases associated with genome stability, we provide
evidence in this review to support an essential, conserved role
of p97 in genome stability from yeast to humans. In addition,
p97 or its adaptors regulate proteins involved in tumorigenesis,
such as Aurora B (overexpressed in cancer cells and implicated
in genome stability), IκB [potential inhibitor of the pro-survival
function of nuclear factor kappa B (NFκB)] or HIF1a (promoter
of tumor angiogenesis and metastases; Asai et al., 2002; Ramadan
et al., 2007; Alexandru et al., 2008; Dobrynin et al., 2011). Ele-
vated p97 expression correlates with the progression, prognosis,
and metastatic potential of many cancers (Yamamoto et al., 2003,
2004a,b,d). For example, high levels of p97 protein correlate with
colorectal carcinomas (Yamamoto et al., 2004c). Low p97 expres-
sion levels have been observed in adenomas, while high levels
have been shown in all metastatic tumors. Patients with tumors
that express high levels of p97 show a higher recurrence rate
and poorer disease-free periods and overall survival compared
to patients with tumors that have low p97 expression, suggest-
ing that high levels of p97 indicate a poor prognosis. Similar to
colorectal cancer, p97 is overexpressed in non-small cell lung carci-
noma (NSCLC; Yamamoto et al., 2004b). All of the data described
are based on a correlation between p97 protein levels and cancer
development and progression. Whether elevated p97 expression
increases the degradation of growth inhibitory proteins or ele-
vated expression is a cellular response to protein-induced stress
in cancer is not known (Haines, 2010). However, inhibition of
p97 by a small molecule signiﬁcantly reduced NSCLC tumor
growth in in vitro and in vivo models (Valle et al., 2011). This
suggests that increased p97 levels may be directly responsible for
tumorigenesis.
There is no evidence that mutations in p97 are related to
cancer. Considering its ubiquitin-dependent functions in diverse
processes related to proliferation and maintenance of protein
homeostasis, one could speculate that cancer cells rely on intact
p97 function.
Because p97 is essential for cell survival, alterations in its adap-
tors would be expected to cause cancer. Haploinsufﬁciency of
the FAF1 gene, a member of the UBX family of adaptors, was
observed in 30% of cervical carcinomas and 12.5% of mantle-cell
lymphomas (Hidalgo et al., 2005; Bea et al., 2009). FAF1 pro-
tein levels are downregulated in gastric carcinomas and a large
percentage of mesotheliomas (Bjorling-Poulsen et al., 2003;
Altomare et al., 2009).
p97 and the FAF1 adaptor likely play important roles in cancer
development, although clearmolecularmechanisms have not been
elucidated.
Direct evidence of p97 involvement in genome stability and
cancer development was recently emerged by the discovery of a
novel premature aging syndrome due to a homozygotic mutation
in the p97 adaptor DVC1. DVC1 recruits p97 to stalled replication
forks and is essential in preventing mutagenesis. A DVC1 muta-
tion in novel premature aging syndrome eliminated recruitment
of p97 to stalled replication forks, which consequently induced
DNA replication fork collapse and an increased level of chro-
mosomal aberrations (our unpublished results, D. Lessel et al.,
submitted).
CONCLUSION
As one of the most abundant cellular proteins, p97 is essential
for cell development, proliferation, and growth. p97 has recently
emerged as a central element in the ubiquitin system involved in
both proteasomal and lysosomal degradation pathways as well as
ubiquitin-dependent, degradation-independent processes. A cen-
tral function of p97 enzymatic activity is to convert its ownATPase
activity into remodeling activity to release (extract) and process a
myriad of ubiquitinated substrates from various cellular locations.
p97 plays an essential role in protein homeostasis and protection
from protein stress due to accumulation of short-lived, misfolded,
old, and damaged proteins. The diversity of p97 related to a myr-
iad of ubiquitinated substrates in a variety of cellular processes is
governed by multiple adaptors. An adaptor hierarchy based on a
second tier of p97 adaptors primarily from the UBX family con-
trols three core p97 adaptor complexes, p97−Ufd1−Npl4, p97−p47,
and p97−UBXD1. Although the role of p97 in the cell cycle and
DNA repair has been known for several decades, its function in
genome stability is beginning to emerge (Figure 4). Elucidation of
CADorchestrated by p97 inDNA replication,DNA repair and dis-
covery of DVC1 has ﬁnally established the role of p97 in genome
stability. This was further demonstrated by discovery of a novel
premature aging syndrome in a human due to a homozygotic
mutation in the p97 adaptor DVC1. Although p97 overexpres-
sion correlates with tumor progression, inactivation of p97 or
its adaptors leads to genome instability. These facts support the
hypothesis that tight regulation of the p97 system is essential for
genome stability and protection against cancer. Understanding
how p97 protects cells from PICHROS and its function in DNA
replication, repair, recombination,mitosis and the cell cycle will be
essential for fully understanding the role of p97 in genome stabil-
ity, aging and cancer. Many questions await further investigation,
such as the identiﬁcation of p97-substrates, adapters, and path-
ways that contribute to genome stability. p97 has a broad range
of adaptors many of which possess ubiquitin-binding domains.
This strongly suggests that p97 most probably binds and modu-
lates variety of ubiquitinated substrates, besides the ones already
known anddescribed in this review,which are essential for genome
stability. Hence, we have to identify other CAD-related substrates
of p97, as well as the composition of p97-adaptor for speciﬁc
substrates related to genome stability. Although it seems simple,
the second tier of p97-adaptors and E3-ubiquitin ligases for many
established pathways and substrates is still unknown, as indicated
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FIGURE 4 | Role of p97 in genome stability.The circle represents a
summary of p97 functions in diverse cellular processes, from yeast to
human, essential for maintenance of genome stability. Key players from
different species are abbreviated with human homologous (e.g., yeast Cdc48
and Ubx5 is equivalent to human p97 and UBXD7). The p97 homohexamer is
centrally located. The ﬁrst ring (blue) represents two core adaptor complexes,
Ufd1–Npl4 and p47. The second ring (orange) represents the next tier of p97
adaptors that direct the function of p97 core complexes. DVC1 directs
p97−Ufd1−Npl4 function towardTLS, and UBXD7 and UBXD9 direct
p97−Ufd1−Npl4 toward stalled transcription andTC-NER. The third ring
(gray) represents E3 ubiquitin ligases that ubiquitinate p97-substrates. The
fourth ring (green) represents p97-substrates that must be remodeled
(extracted) by p97 to avoid PICHROS and prevent genome instability.
The ﬁfth ring (white) represents different cellular processes in which
p97 plays an essential role for maintenance of genome stability. PP1,
protein phosphates 1/Glc7 in yeast; CDK inhibitor, cyclin-dependent
kinase inhibitor Far1p in yeast; L3MBTL1, polycomb protein that
contains malignant brain tumor (MBT) domain; CDT1, chromatin
licensing and DNA replication factor 1; SET8, histone methyltransferase;
XMAP215, processive microtubule polymerase; TPX2, microtubule
associated protein; PLX1, polo-like kinase; DNA pol δ and η DNA polymerases
delta and eta.
by question marks in Figure 4. In addition to its role in numer-
ous cellular processes (Figure 4; ﬁfth ring), p97 most probably
also plays a role in other ubiquitin-controlled pathways and pro-
cesses that directly regulate genome stability, such as base excision
repair, mismatch repair, DNA damage checkpoints, and apop-
tosis. Finally, understanding the complex function of p97, its
adaptors and substrates in genome stability might directly help
to develop a new and more efﬁcient anti-cancer drug(s). This
speculation is based on effects of bortezomib (Velcade), a protea-
some inhibitor currently used for treatment of multiple myeloma
and mantle-cell lymphoma and fascinating results showing that
p97 inhibitor signiﬁcantly reduced NSCLC tumor growth in in
vitro and in vivo models (Valle et al., 2011). Taken together, one
anticipates interesting and dynamic time ahead in investigating
the function of p97 in the context of genome stability and cancer
therapy.
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